Luis B Marrero, MD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 23 Kennedy St, Suite 302, Bradford, PA 16701 Phone: 814-362-9804 Fax: 814-362-6571 |
News Archive
Heart care in France ranks 1st among 30 measured countries, says the Euro Heart Index 2016 (EHI), published today in Brussels. The Index compares heart care in 30 European countries, with France the champion, closely followed by Norway and Sweden.
People who have had an episode of herpes zoster, also known as shingles, face a relatively low short-term risk of developing shingles, according to a Kaiser Permanente Southern California study published online in the Journal of Infectious Diseases. These findings suggest that among people with immune systems that have not been compromised, the risk of a second shingles episode is low.
More than 900 scientists, parents and activists from around the world who are focused on understanding the causes of autism and finding treatments for the developmental disorder will gather in Seattle May 3-5 to share the latest research findings at the sixth annual International Meeting for Autism Research.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals International GmbH, today announced that the European Commission has granted Marketing Authorisation for Entyvio (vedolizumab), a gut-selective humanized monoclonal antibody, and the first and only biologic therapy to be approved simultaneously for the treatment of adults with moderately to severely active ulcerative colitis (UC) and adults with moderately to severely active Crohn's disease (CD) who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumor necrosis factor-alpha (TNFα) antagonist.
› Verified 4 days ago